Changing paradigms of hemophilia care across larger specialized treatment centers in the European region.

导出 LinkOut

翻译打印收藏纠错

作者： Jerzy,Windyga ^[1] ; Ana,Boban ^[2] ; Irena,Zupan ^[3] ; Niamh,O'Connell ^[4] ; Cedric,Hermans ^[5]

作者单位： Laboratory of Hemostasis and Metabolic Diseases, Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland. ^[1] Haemophilia Centre, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia. ^[2] Department of Haematology, University Medical Centre Ljubljana, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. ^[3] The National Coagulation Centre, St James's Hospital and Trinity College Dublin, Dublin, Ireland. ^[4] Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium. ^[5]

关键词 Bleeding disorders emicizumab gene therapy hemophilia hemophilia treatment centers management guidelines novel hemophilia therapies outcomes prophylaxis treatment

DOI 10.1177/20406207221088462

PMID 35371429

发布时间 2022-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in hematology

2022年13卷

20406207221088462页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Changing paradigms of hemophilia care across larger specialized treatment centers in the European region.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Changing paradigms of hemophilia care across larger specialized treatment centers in the European region.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

检索历史清除